Rosadan GEL 0.75 % Topical Gel
RxNorm 1251688
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 1251688 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Rosadan GEL 0.75 % Topical Gel.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SBDPrescribable
Semantic Branded Drug (SBD):
Metronidazole 0.0075 mg/MG Topical Gel [Rosadan]
(Atom ID: 12367997)
TMSYPrescribable
Tall Man Lettering Synonym (TMSY):
MetroNIDAZOLE 0.0075 mg/MG Topical Gel [Rosadan]
(Atom ID: 4262680)
SYPrescribable
Synonym (SY):
Rosadan 0.0075 mg/MG Topical Gel
(Atom ID: 4262252)
SYPrescribable
Synonym (SY):
Rosadan 0.75 % Topical Gel
(Atom ID: 4610422)
PSNPrescribable
Prescribable Name (PSN):
Rosadan GEL 0.75 % Topical Gel
(Atom ID: 6397284)
Patient Education
Metronidazole Topical
Metronidazole is used to treat rosacea (a skin disease that causes redness, flushing, and pimples on the face). Metronidazole is in a class of medications called nitroimidazole antimicrobials. It works by stopping the growth of bacteria.
[Learn More]
* Please review the disclaimer below.